EUVIMEDEUVIMED entdecken
Fallbericht

Stroke in Young Military Men With Heterozygous for MTHFR Gene Mutation or Factor V Leiden Gene Mutation Associated With Patent Foramen Ovale: Report of Two Cases and Therapeutic Strategy

Rodrigo Tavares Brisson iD, Josevânia Fulgêncio de Lima Arruda, Liene Duarte Silva iD, Dilermando Leal Júnio de Jesus, Viviane Flumignan Zetola iD, Marcia Aparecida Camacho Kauffmann Nogueira

Military Medicine · 2023

DOI: 10.1093/milmed/usab192 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Military Medicine, 2023. Verfasst von Rodrigo Tavares Brisson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Hospital Naval Marcílio Dias, Rio de Janeiro, Rio de Janeiro 20725-090, Brazil. Hauptthemen laut MEDLINE: Foramen Ovale, Patent, Ischemic Stroke, Military Personnel, Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report two cases of Brazilian patients (a 22-year-old male and a 48-year-old male) with ischemic stroke, whose arterial vascular study and echocardiographic investigation did not reveal any steno-occlusive arterial disease or typical cardioembolic finding, such as atrial fibrillation or myocardial dysfunction. A transcranial Doppler ultrasound and a transesophageal echocardiogram showed a patent foramen ovale (PFO), and the laboratory screening for coagulation abnormalities showed heterozygosity for MTHFR C677T and A1298C in one of the patients and heterozygosity for factor V Leiden gene mutations in the other patient. The significance of the association of PFO with Methylenetetrahydrofolate (MTHFR) C677T and A1298C variants or factor V Leiden mutation is discussed as a possible cause of ischemic stroke through paradoxical embolism from a venous source. There is a high prevalence of these two mentioned conditions in the general population, so we discuss two cases in which indication for anticoagulant therapy or percutaneous closure of PFO prevails.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Foramen Ovale, PatentIschemic StrokeMilitary PersonnelStrokeHumansMaleMiddle AgedYoung AdultMethylenetetrahydrofolate Reductase (NADPH2)MutationRisk FactorsFactor VThrombophilia

Substanzen

Methylenetetrahydrofolate Reductase (NADPH2)factor V LeidenFactor VMTHFR protein, human

Autor:innen und Institutionen

  • Division of Neurology, Hospital Naval Marcílio Dias, Rio de Janeiro, Rio de Janeiro 20725-090, Brazil.
  • Neurosonology Laboratory, Cerebrovascular Disease Unit, Federal University of Paraná, Curitiba, Paraná 80060-000, Brazil.

ORCID-Profile: Rodrigo Tavares Brisson, Liene Duarte Silva, Viviane Flumignan Zetola

Zitieren

APA

Brisson, R. T., Arruda, J. F. L., Silva, L. D., de Jesus, D. L. J., Zetola, V. F., & Kauffmann Nogueira, M. A. C. (2023). Stroke in Young Military Men With Heterozygous for MTHFR Gene Mutation or Factor V Leiden Gene Mutation Associated With Patent Foramen Ovale: Report of Two Cases and Therapeutic Strategy. Military Medicine. https://doi.org/10.1093/milmed/usab192

Vancouver

Brisson RT, Arruda JFL, Silva LD, de Jesus DLJ, Zetola VF, Kauffmann Nogueira MAC. Stroke in Young Military Men With Heterozygous for MTHFR Gene Mutation or Factor V Leiden Gene Mutation Associated With Patent Foramen Ovale: Report of Two Cases and Therapeutic Strategy. Military Medicine. 2023. doi:10.1093/milmed/usab192

BibTeX
@article{Brisson2023,
  author = {Brisson, Rodrigo Tavares and Arruda, Josevânia Fulgêncio de Lima and Silva, Liene Duarte and de Jesus, Dilermando Leal Júnio and Zetola, Viviane Flumignan and Kauffmann Nogueira, Marcia Aparecida Camacho},
  title = {Stroke in Young Military Men With Heterozygous for MTHFR Gene Mutation or Factor V Leiden Gene Mutation Associated With Patent Foramen Ovale: Report of Two Cases and Therapeutic Strategy},
  journal = {Military Medicine},
  year = {2023},
  doi = {10.1093/milmed/usab192}
}
Kostenlos starten →